Shanil Naidoo

Learn More
INTRODUCTION AND OBJECTIVES Cardiovascular disease (CVD) is the leading cause of mortality worldwide and increased levels of low-density lipoprotein cholesterol (LDL-C) are an important modifiable risk factor. Statins lower LDL-C levels and have been shown to reduce CVD risk. Despite the widespread availability of statins, many patients do not reach the(More)
INTRODUCTION • Triple-negative breast cancer (TNBC) represents 10%–20% of invasive breast cancers1 and has a very poor prognosis.2 There is a particular unmet need in TNBC, with a lack of clinically established targeted therapies3; chemotherapy is the only option for metastatic TNBC.4 • To facilitate access to new treatments, it is increasingly important to(More)
PCN248 Cost-Utility ANAlysis of ENzAlUtAmidE for PAtiENts With ChEmothErAPy-NAïvE mEtAstAtiC CAstrAtioN-rEsistANt ProstAtE CANCEr (mCrPC) AftEr fAilUrE of ANdrogEN dEPrivAtioN thErAPy (Adt) Vicente C1, Loblaw A2, North S3, Kassouf W4, Naidoo S5, Husein F6, Nakhaipour HR6 1PIVINA Consulting Inc., Mississauga, ON, Canada, 2University of Toronto, Toronto, ON,(More)
  • 1